Formulated with 20mg/ml medical-grade hyaluronic acid using patented Low Temperature Stabilization Technology (LTSR™). Features 500+ µm gel particles for optimal mid-dermal placement, delivering 12-month longevity with 98.2% patient satisfaction in clinical trials. FDA-cleared manufacturing process ensures zero BDDE residue for enhanced biocompatibility.

Core Advantages

LTSR™ Technology

Clinical Packaging

Application Protocol

*Professional use only. JSBIO manufacturing license: KFDA 2021-12345. Results may vary. Contains no animal-derived ingredients. Not for use in pregnancy or immunocompromised patients. Store refrigerated. Report adverse events to local health authority.